AHF: J&J’s Record $2 Billion Fine Shows Pharma’s ‘Unbridled Greed’ Department of Justice fines Johnson & Johnson a record $2.2 billion; Action underscores a growing pattern of abuse fueled by the unbridled greed of J&J and others in the pharmaceutical industry Last week, AHF sued Johnson & Johnson in the Superior Court of California for cheating on its AIDS drug pricing, overcharging AHF by as much as $2 million on HIV/AIDS drugs between 2005-2012 Business Wire LOS ANGELES -- November 5, 2013 As news broke yesterday that the United States Department of Justice leveled a $2.2 billion fine against Johnson & Johnson (J&J) to settle civil and criminal charges that the pharmaceutical giant illegally marketed one of its antipsychotic drugs and other medications for off-label use as well as paid illegal kickbacks to a pharmacy, the AIDS Healthcare Foundation (AHF), the largest global AIDS organization, noted that the DOJ’s action and record fine against J&J underscores the unbridled greed of the entire pharmaceutical industry. “Kudos to the Justice Department for holding J&J, one of America’s most trusted brands—from Johnson’s baby powder and shampoo to Tylenol and its prescription medications—accountable for its illegal, and quite brazen, marketing activities and kickbacks,” said Michael Weinstein, President of AHF. “Sadly, this DOJ action underscores a growing pattern of abuse by Pharma and epitomizes the unbridled greed of both J&J and the pharmaceutical industry as a whole.” Separately, AHF last week sued Johnson & Johnson and its subsidiaries in the Superior Court of California for cheating on its AIDS drug pricing and overcharged AHF by as much as $2 million on HIV/AIDS drugs purchased between 2005-2012. AHF’s lawsuit alleges that the companies have “…failed to fully satisfy their obligations with respect to the drugs they sold to AHF over a period of many years,” under the 340B Program, a Federal drug discount program designed to stretch scarce Federal resources as far as possible for safety net healthcare providers such as AHF. The J&J Companies include Johnson & Johnson, Janssen Therapeutics and Janssen Biotech. Together, they control a significant portion of the AIDS drug market with drugs that include Prezista, Intelence, Endurant and Procrit. AHF’s lawsuit against J&J was filed Wednesday, October 30, 2013 in the Superior Court of California, County of Los Angeles, Central District [case #BC526253]. The action against J&J includes claims of “Violation of California Unfair Competition Law; Breach of Contract—Third Party Beneficiary; Negligence; Unjust Enrichment and Breach of Covenant of Good Faith and Fair Dealing.” About AIDS Healthcare Foundation AIDS Healthcare Foundation (AHF), the largest global AIDS organization, currently provides medical care and/or services to more than 250,000 individuals in 32 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Eastern Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare. Contact: AIDS Healthcare Foundation Ged Kenslea, Senior Director, Communications Tel: (323) 308-1833, Cell: (323) 791-5526 email@example.com or AIDS Healthcare Foundation Laura Boudreau, Chief Counsel for Operations Tel: (323) 860-5202 firstname.lastname@example.org
AHF: J&J’s Record $2 Billion Fine Shows Pharma’s ‘Unbridled Greed’
Press spacebar to pause and continue. Press esc to stop.